https://www.semanticscholar.org/topic/Dipeptidyl-Peptidase-4-Inhibitor/1088870
Dipeptidyl Peptidase-4 Inhibitor | Semantic Scholar
Any inhibitor of the proline-specific serine protease dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. DPP-4 inhibitors bind to DPP-4 and inhibit...
dipeptidyl peptidase 4inhibitorsemanticscholar
https://www.fda.gov/drugs/information-drug-class/information-dipeptidyl-peptidase-4-dpp-4-inhibitors
Information on Dipeptidyl Peptidase-4 (DPP-4) Inhibitors | FDA
Information on Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
dipeptidyl peptidase 4information ondppinhibitorsfda
https://www.cochrane.org/evidence/CD006739_dipeptidyl-peptidase-4-dpp-4-inhibitors-type-2-diabetes-mellitus
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus | Cochrane
for type 2 diabetesdipeptidyl peptidase 4dppinhibitors
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1518545/full
Frontiers | Association of long-term use of dipeptidyl peptidase-4 inhibitors with the risk of...
BackgroundIn this study, we investigated the association of long-term use of a dipeptidyl peptidase-4 inhibitor (DPP-4i) with the risk of diabetic retinopath...
dipeptidyl peptidase 4
https://www.thebusinessresearchcompany.com/report/dipeptide-peptidase-4-inhibitors-global-market-report
Dipeptidyl Peptidase 4 Inhibitors Market Size Report 2035
The Dipeptide Peptidase 4 Inhibitors market size is expected to reach $14.78 billion in 2030 at a CAGR of 4.5%, driven by rising diabetes prevalence.
dipeptidyl peptidase 4market sizeinhibitorsreport2035